Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-16-025724

Chief Financial Officer bought 16,000 shares at an average $3.12 ($49,862)

From the SEC's structured data for this filing

Trades in this filing

Allen Patricia L · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-07-25 Purchase : show line 1 in the form +7,800 $3.08 $24,032 11,593 D
2016-07-26 Purchase : show line 2 in the form +8,200 $3.15 $25,830 19,793 D
Open-market purchases · 16,000 sh · avg $3.12 · $49,862
Loading xslF345X03/doc4.xml…